Using flow cytometry, we found that TGF‐β1 neutralisation decreases the percentage of leukocytes, CD4+ cells, Th1 cells, Th2 cells and neutrophils in the skin, suggesting that this treatment has broad anti‐inflammatory effects in lymphedema (Figure 3E, Supplemental Figure S3D). Here, CD4 is linked to lymphedema.